Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC (MRD-LUNG)
GUIding Multi-moDal thErapies Against MRD by LiquidBiopsies in Non Small Cell Lung Cancer- GUIDE.MRD-03-NSCLC
Sponsor: Centre Hospitalier Universitaire de Nice
This observational or N/A phase trial investigates Lung Cancer Stage III and is currently actively recruiting participants. Centre Hospitalier Universitaire de Nice leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
7 versions recorded-
Jun 2025 — Present [monthly]
Recruiting
-
Apr 2025 — Jun 2025 [monthly]
Recruiting
-
Sep 2024 — Apr 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Jan 2024 — Mar 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Dec 2023 — Jan 2024 [monthly]
Not Yet Recruiting
First recorded
Nov 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Nice
- LungenClinic Grosshansdorf
- University Medical Center Groningen
For direct contact, visit the study record on ClinicalTrials.gov .